Log in · Sign up
GILEAD SCIENCES, INC. (GILD) reported Accounts receivable of USD 5,055,000,000 as of 2026-06-30 in its 10-Q (accession 0000882095-26-000031, filed 2026-08-06).
| Period | Value | Verify |
|---|---|---|
| 2026-06-30 | $5,055,000,000 | EDGAR ↗ |
| 2025-12-31 (comparative) | $4,913,000,000 | EDGAR ↗ |
Company GILEAD SCIENCES, INC. · CIK 882095
Form 10-Q · Accession 0000882095-26-000031 · Filed 2026-08-06
XBRL tag us-gaap:AccountsReceivableNetCurrent · unit USD · instant
Values are read directly from the inline XBRL the company filed with EDGAR. The EDGAR links above point to the exact figure inside the filing document. No ratios or interpretation are added here.
GILEAD SCIENCES, INC. (GILD) reported Accounts receivable of USD 5,055,000,000 as of 2026-06-30 in its 10-Q (accession 0000882095-26-000031, filed 2026-08-06).
— aiSwingX, https://aiswingx.com/n/0000882095-26-000031/AccountsReceivableNetCurrent
JSON: /api/v1/facts/0000882095-26-000031/AccountsReceivableNetCurrent